Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: Dependence on cyclic guanosine monophosphate and modulation of catecholamine effects

Diabetologia

Volumn 39, Issue 10, 1996, Pages 1156-1164

  Trovati, M ^a   Massucco, P ^a   Mattiello, L ^a   Cavalot, F ^a   Mularoni, E M ^a   Hahn, A W ^b   Anfossi, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Arterial hypertension; Catecholamines; Cyclic adenosine monophosphate; Cyclic guanosine monophosphate; Insulin; Nitric oxide; Vascular smooth muscle cells

Indexed keywords

ADRENALIN; CATECHOLAMINE; CYCLIC AMP; CYCLIC GMP; INSULIN; ISOPRENALINE; METHYLENE BLUE; N(G) METHYLARGININE; NORADRENALIN; PROPRANOLOL; SALBUTAMOL; YOHIMBINE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 0029782271     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02658501     Document Type: Article

References (54)

1. Trovati M, Massucco P, Mattiello L, Cavalot F, Mularoni E, Hahn A, Anfossi G (1995) Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. Diahetologia 38: 936-941
2. Gryglewski RJ, Korhut R, Kalecinska A, Zemhowicz A (1989) Interaction between stimulators of adenylate and guanylate cyclases in human leukocytes, platelets and arteries. Int J Tiss React 11: 269-274
3. Maurice DH, Haslam RJ (1990) Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol 37: 671-681
4. Anfossi G, Massucco P, Mularoni E, Cavalot F, Mattiello L, Trovati M (1993) Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost. Prostaglandins Leukot Essent Fatty Acids 49: 839-845
5. Anfossi G, Massucco P, Mularoni E, Cavalot F, Mattiello L, Trovati M (1994) Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets. Gen Pharmacol 25: 1093-1100
6. Tateson J, Moncada S, Vane JR (1977) Effects of prostacyclin on cyclic AMP concentrations in human platelets. Prostaglandins 13:343-399
7. Seamon KB, Daly JW (1983) Forskolin, cyclic AMP and cellular physiology. Trend Pharmacol Sci 4: 120-132
8. Norman AW, Litwack G (1987) Hormones. Academic Press Inc. Orlando, Florida pp471-478
9. 2-adrenergic receptor-mediated contraction of vascular smooth muscle. Circ Res 72: 778-785
10. Lembo G, Napoli R, Capaldo B et al. (1992) Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest 90: 24-29
11. Vollenweider P, Randin D, Tappy L, Jéquier E, Nicod P, Scherrer U (1994) Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 93: 2365-2371
12. Vollenweider L, Tappy L, Owlya R, Jéquier E, Nicod P, Scherrer U (1995) Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes 44: 641-645
13. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL (1991) Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87: 2246-2252
14. Berne C, Fagius J, Pollare T, Hjemdahl P (1992) The sympathetic response to euglycaemic hyperinsulinaemia: evidence from microelectrode nerve recordings in healthy subjects. Diahetologia 35: 873-879
15. Scherrer U, Vollenweider P, Randin D, Jéquier E, Nicod P, Tappy L (1993) Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation 88: 388-394
16. Vollenweider P, Tappy L, Randin D, Schneiter P, Jéquier E, Nicod P, Scherrer U (1993) Differential effects of hyperin-sulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 92: 147-154
17. Page MM, Watkins PJ (1976) Provocation of postural hypotension by insulin in diabetic autonomic neuropathy. Diabetes 25: 90-95
18. Takata S, Yamamoto M, Yagi S, Noto Y, Ikeda T. Hattori N (1985) Peripheral circulatory effects of insulin in diabetes. Angiology 36: 110-115
19. Porcellati F, Fanelli C, Bottini P et al. (1993) Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy. Diabetes 42: 1055-1064
20. Sakai K, Imaizumi T, Masaki H, Takeshita A (1993) Intraarterial infusion of insulin attenuates vasoreactivity in human forearm. Hypertension 22: 67-73
21. Jern S (1994) Effects of insulin on vascular responses to mental stress and norepinephrine in human forearm. Hypertension 24: 694-696
22. Lembo G, Rendina V, Iaccarino G, Lamenza F, Volpe M, Trimarco B (1993) Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans. Hypertension 21: 1015-1019
23. Baron AD, Brechtel G, Johnson A, Fineberg N, Henry DP, Steinberg HO (1994) Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity. Studies in lean and obese men. J Clin Invest 93: 2453-2462
24. Alexander WD, Oake RJ (1977) The effect of insulin on vascular reactivity to norepinephrine. Diabetes 26: 611-614
25. Yagi S, Takata S, Kiyokawa H, Yamamoto M, Noto Y, Ikeda T, Hattori N (1988) Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein. Diabetes 37: 1064-1067
26. Wambach GK, Liu D (1992) Insulin attenuates vasoconstriction by noradrenaline, serotonin and potassium chloride in rat mesenteric arterioles. Clin Exp Hypertens A 14: 733-740
27. McNally PG, Lawrence IG, Watt PAC, Millier C, Burden AC, Thurston H (1995) The effect of insulin on the vascular reactivity of isolated resistance arteries taken from healthy volunteers. Diabetologia 38: 467-473
28. Savage MW, Bodmer CW, Walker AB, Buchan IE, Masson EA, Williams G (1995) Vascular reactivity to noradrenaline and neuropeptide Y in streptozotocin-induced diabetic rat. Eur J Clin Invest 25: 974-979
29. Saito F, Hori MT, Fittingoff M, Hino T. Tuck ML (1993) Insulin attenuates agonist mediated calcium mobilization in cultured rat vascular smooth muscle cells. J Clin Invest 92: 1161-1167
30. Standley PR, Zhang F, Ram JL, Zemel MB, Sowers JR (1991) Insulin attenuates vasopressin-induced calcium transients and voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest 88: 1230-1236
31. Steinberg HO, Brechtel G, Johnson A, Fineberg N. Baron A (1994) Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94: 1172-1179
32. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P (1994) Nitric oxide release accounts tor insulin's vascular effects in humans. J Clin Invest 94: 2511-2515
33. 2-adrenergic pathway in humans. Hypertension 24: 429-438
34. 2 adrenergic receptor numbers in platelets by insulin. Biochim Biophys Acta 1134: 292-296
35. Winecoff AP, Tackett RL, Fuchs LC (1995) Insulin attenuates α-adrenergic aortic contraction in normotensive but not in borderline hypertensive rats. Clin Exp Hypertens 17: 787-801
36. Zemel M, Reddy S, Sowers J (1991) Insulin attenuation of vasoconstrictor responses to phenylephrine in Zucker lean and obese rats. Am J Hypertens 4: 537-539
37. Gros R, Borkowski KR, Feldman RD (1994) Human insulin-mediated enhancement of vascular β-adrenergic responsiveness. Hypertension 23: 551-555
38. Creager MA, Liang C-S. Coffman JD (1985) Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther 235: 709-714
39. Randin D, Vollenweider P, Tuppy L, Jequier E, Nicod P, Scherrer U (1994) Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans. Am J Physiol 266: R809-R816
40. Trovati M, Anfossi G, Cavalot F et al. (1986) Studies on mechanisms involved in hypoglycaemia-induced platelet activation. Diabetes 35: 818-825
41. Trovati M, Massucco P, Mularoni E, Cavalot F, Anfossi G, Mattiello L, Emanuelli G (1988) Insulin-induced hypoglycaemia increases plasma concentrations of angiotensin II and does not modify atrial natriuretic polypeplide secretion in man. Diabetologia 31: 816-820
42. Trovati M, Anfossi G, De Facis R et al. (1992) Moderate exercise increases platelet function in type 1 diabetic patients without severe angiopathy and in a good control. Diabetes Care 15 [Suppl 4]: 1742-1746
43. Scott-Burden T, Resink TJ, Hahn AWA, Baur U, Box RJ, Buhler FR (1989) Induction of growth-related metabolism in human vascular muscle cells by low density lipoprotein. J Biol Chem 264: 12582-12589
44. Trovati M, Massucco P, Mattiello L, Mularoni E, Cavalot F, Anfossi G (1994) Insulin increases guanosine-3′. 5′-cyelic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect. Diabetes 43: 1015-1019
45. Trovati M, Mularoni E, Burzacca S et al. (1995) Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients. Diabetes 44: 1318-1322
46. Trovati M, Anfossi G, Cavalot F, Massucco P, Mularoni E. Emanuelli G (1988) Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo. Diabetes 37: 780-786
47. Trovati M, Massucco P, Mattiello L, Piretto V, Cavalot F, Mularoni E. Anfossi G (1996) The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide. Diabetes 45: 768-770
48. Solomon SS, Palazzolo M, King LE (1977) Cyclic nucleotide phosphodiesterase. Insulin activation detected in adipose tissue by gel electrophoresis. Diabetes 26: 967-979
49. Conti M, Jin S-L C, Monaco L, Repaske DR, Swinnen JV (1991) Hormonal regulation of cyclic phosphodiesterases. Endocr Rev 12:218-234
50. Lopez-Aparicio P, Rascon A, Manganiello VC, Andersson KE, Belfrage P, Degerman E (1992) Insulin induced phos-phorylation and activation of the cGMP-inhibited cAMP phosphodiesterase in human platelets. Biochem Biophys Res Commun 186: 517-523
51. 1/prostacyclin and insulin in human erythrocytes and platelets. Life Sci 49: 1129-1139
52. Anfossi G, Trovati M, Mularoni E, Massucco P, Calcamuggi G, Fmanuelli G (1989) Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood. Prostaglandins Leukot Essent Fatty Acids 36: 1-7
53. De Fronzo RA, Ferrannini F (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia. and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194
54. Grover A, Padginton C, Wilson MF, Sung BH, Izzo JL, Dandona P (1995) Insulin attenuates noreptnephrine-induced venoconstriction. An ultrasonographic study. Hypertension 25 [part 2]: 779-784